Logica’s WebFormulogic applications are designed to support the business processes and methods used by the formulation teams, including the use of multiple, parallel formulations, experimental design and problem solving. The solution can be configured to use information based on the characteristics of the ingredients, manufacturing processes, ingredients costs and many other parameters.
This project represents the latest development in a ten-year working relationship between AstraZeneca and Logica. During this time, Formulogic, a trusted and proven solution for our business has provided us with a vital knowledge management tool for our formulation work in new product development. Logica’s new web-enabled version of Formulogic, WebFormulogic, supports us in our objectives to assist our international team collaborating on common projects and processes, affirmed Dr Chris Doherty, director, Product Development, AstraZeneca, in a statement to the press.
He continued: Now, our formulation processes can be deployed globally and several different new product development groups can use it at any one time, providing us with a competitive advantage to bring new drugs to market faster and more efficiently.
Professor Ray Rowe of AstraZeneca, an industry expert in this field and leader of the PROFITS Special Interest group at the University of Bradford explained: Expert systems are ideally suited to supporting the formulation process and WebFormulogic has been specifically designed as an easy to use system to enable rapid development of new dosage forms.
Ultimately, WebFormulogic will allow AstraZeneca to globalize standards and quality in the formulation of new pharmaceuticals, bringing them to market more rapidly
